Showing results (21-30 of 101) with videos related to
Sort By:
Pageof 11
Leukemia & Lymphoma|November 17, 2006
Optimizing treatment for elderly patients with acute promyelocytic leukemia: is it time to replace chemotherapy with all-trans retinoic acid and arsenic trioxide?Apostolia-Maria Tsimberidou, Hagop Kantarjian, Michael J Keating, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Ultimate fate of oncology drugs approved by the us food and drug administration without a randomized TrialApostolia-Maria Tsimberidou, Fadi Braiteh, David J Stewart, et al.Journal of the National Cancer Institute|April 6, 2021
Wedding of Molecular Alterations and Immune Checkpoint Blockade: Genomics as a MatchmakerElena Fountzilas, Razelle Kurzrock, Henry Hiep Vo, et al.Cancer Treatment Reviews|March 14, 2024
Tumor-agnostic baskets to N-of-1 platform trials and real-world data: Transforming precision oncology clinical trial designElena Fountzilas, Apostolia-Maria Tsimberidou, Henry Hiep Vo, et al.Cancer|January 28, 2004
Activity of interferon-alpha and isotretinoin in patients with advanced, refractory lymphoid malignanciesApostolia-Maria Tsimberidou, Francis Giles, Jorge Romaguera, et al.Cancer|January 13, 2004
Phase II study of pentostatin in advanced T-cell lymphoid malignancies: update of an M.D. Anderson Cancer Center seriesApostolia-Maria Tsimberidou, Francis Giles, Madeleine Duvic, et al.Therapeutic Advances in Medical Oncology|May 17, 2021
Prolonged response to treatment based on cell-free DNA analysis and molecular profiling in three patients with metastatic cancer: a case seriesMohammad Faraz Naqvi, Henry Hiep Vo, David Vining, et al.Leukemia & Lymphoma|June 7, 2006
Epstein-Barr virus in patients with chronic lymphocytic leukemia: a pilot studyApostolia-Maria Tsimberidou, Michael J Keating, Carlos E Bueso-Ramos, et al.Data in Brief|November 29, 2023
Dataset of phase I and II immunotherapy clinical trials used for a meta-analysis to assess the role of biomarkers in treatment outcomes in diverse cancersElena Fountzilas, Henry Hiep Vo, Peter Mueller, et al.European Journal of Cancer (Oxford, England : 1990)|June 26, 2023
Correlation between biomarkers and treatment outcomes in diverse cancers: a systematic review and meta-analysis of phase I and II immunotherapy clinical trialsElena Fountzilas, Henry Hiep Vo, Peter Mueller, et al.Pageof 11